|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.07 AUD | -1.41% |
|
-2.78% | -36.36% |
Imugene Limited announced the appointment of Chief Financial Officer (CFO) Mike Tonroe as Company Secretary, effective 2 March 2023. Mr. Tonroe commenced as CFO of Imugene in September 2022. In addition to being an experienced CFO, Mr. Tonroe was previously Company Secretary of Genetic Technologies Limited and Opthea Limited.
Phillip Hains and Nathan Jong will step down as Company Secretaries effective 2 March 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -36.36% | 340M | |
| +67.53% | 63.85B | |
| -0.77% | 41.83B | |
| +45.66% | 40.65B | |
| -10.72% | 27.12B | |
| +13.30% | 26.52B | |
| -22.79% | 18.69B | |
| +4.70% | 12.73B | |
| +24.10% | 12.11B | |
| +27.41% | 12.07B |
IMUGENE LIMITED 
